Cadherin-catenin Expression in Primary Colorectal Cancer: a Survival Analysis

Overview

Journal Br J Cancer

Specialty Oncology

Date 1999 Jun 11

PMID 10362114

Citations 31

Authors

T J Hugh

S A Dillon

B A Taylor

M Pignatelli

G J Poston

A R Kinsella

Affiliations

Soon will be listed here.

Abstract

Both cell adhesion and cell signalling events are mediated by components of the cadherin-catenin complex. Loss of expression of the components of this complex have been shown to correlate with invasive behaviour in many tumour types although their exact role in colorectal cancer remains unclear. Immunohistochemical analysis of the expression of components of the cadherin-catenin complex in colorectal cancers from 60 patients was undertaken. Loss of memberanous expression of E-cadherin, alpha-catenin and beta-catenin was demonstrated in 52%, 85% and 40% of tumours respectively. Focal nuclear expression of beta-catenin (< 75% of cells per section), usually associated with cytoplasmic expression, was clearly demonstrated in 19 (32%) tumours while widespread nuclear expression (> 75% of tumour cells per section) was seen in 11 (18%) tumours. Loss of membranous alpha-catenin expression significantly correlated with tumour de-differentiation (P = 0.009). There was a trend towards an association between advanced tumour stage and loss of membranous expression of alpha-catenin or beta-catenin, although these associations were not statistically significant. Univariate analysis revealed that advanced Dukes' stage, tumour de-differentiation, loss of membranous beta-catenin expression, cytoplasmic beta-catenin expression and widespread nuclear expression of beta-catenin all correlated with short survival following apparently curative resection of the primary tumour. However, only Dukes' stage (P = 0.002), tumour grade (P = 0.02) and widespread nuclear expression of beta-catenin (P = 0.002) were independent predictors of short survival. Disturbed growth signalling events in colorectal tumours are thought to result in nuclear accumulation of beta-catenin. Consequently, tumours with widespread nuclear expression of beta-catenin are likely to have severely abnormal growth characteristics, and which therefore might be predictive of short survival in these patients.

Citing Articles

Association between the expression of epithelial-mesenchymal transition (EMT)-related markers and oncologic outcomes of colorectal cancer.

Emile M, Emile S, El-Karef A, Ebrahim M, Mohammed I, Ibrahim D Updates Surg. 2024; 76(6):2181-2191.

PMID: 38762631 PMC: 11541317. DOI: 10.1007/s13304-024-01865-9.

A Case of Colonic Micropapillary Carcinoma with a High Frequency of Apoptosis.

Arai K, Iwasaki T, Ishimatsu H, Tsuchiya C, Kubota A, Sonoda A J Gastrointest Cancer. 2021; 53(3):809-816.

PMID: 34302254 DOI: 10.1007/s12029-021-00674-2.

Exon 3 mutations of drive tumorigenesis: a review.

Gao C, Wang Y, Broaddus R, Sun L, Xue F, Zhang W Oncotarget. 2018; 9(4):5492-5508.

PMID: 29435196 PMC: 5797067. DOI: 10.18632/oncotarget.23695.

Vitamin D postpones the progression of epithelial ovarian cancer induced by 7, 12-dimethylbenz [a] anthracene both in vitro and in vivo.

Liu L, Hu Z, Zhang H, Hou Y, Zhang Z, Zhou G Onco Targets Ther. 2016; 9:2365-75.

PMID: 27143932 PMC: 4846061. DOI: 10.2147/OTT.S100581.

Vitamins in pancreatic cancer: a review of underlying mechanisms and future applications.

Davis-Yadley A, Malafa M Adv Nutr. 2015; 6(6):774-802.

PMID: 26567201 PMC: 4642423. DOI: 10.3945/an.115.009456.

References

Morton R, Ewing C, Nagafuchi A, Tsukita S, Isaacs W . Reduction of E-cadherin levels and deletion of the alpha-catenin gene in human prostate cancer cells. Cancer Res. 1993; 53(15):3585-90. View

Iwao K, Nakamori S, Kameyama M, Imaoka S, Kinoshita M, Fukui T . Activation of the beta-catenin gene by interstitial deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations. Cancer Res. 1998; 58(5):1021-6. View

Kadowaki T, Shiozaki H, Inoue M, Tamura S, Oka H, Doki Y . E-cadherin and alpha-catenin expression in human esophageal cancer. Cancer Res. 1994; 54(1):291-6. View

Matsui S, Shiozaki H, Inoue M, Tamura S, Doki Y, Kadowaki T . Immunohistochemical evaluation of alpha-catenin expression in human gastric cancer. Virchows Arch. 1994; 424(4):375-81. DOI: 10.1007/BF00190559. View

Hinck L, Nathke I, Papkoff J, Nelson W . Dynamics of cadherin/catenin complex formation: novel protein interactions and pathways of complex assembly. J Cell Biol. 1994; 125(6):1327-40. PMC: 2290923. DOI: 10.1083/jcb.125.6.1327. View

Kinsella A, Lepts G, Hill C, Jones M . Reduced E-cadherin expression correlates with increased invasiveness in colorectal carcinoma cell lines. Clin Exp Metastasis. 1994; 12(4):335-42. DOI: 10.1007/BF01753841. View

Dorudi S, Hanby A, Poulsom R, Northover J, Hart I . Level of expression of E-cadherin mRNA in colorectal cancer correlates with clinical outcome. Br J Cancer. 1995; 71(3):614-6. PMC: 2033614. DOI: 10.1038/bjc.1995.119. View

Gagliardi G, Kandemir O, Liu D, Guida M, Benvestito S, Ruers T . Changes in E-cadherin immunoreactivity in the adenoma-carcinoma sequence of the large bowel. Virchows Arch. 1995; 426(2):149-54. DOI: 10.1007/BF00192636. View

Jou T, Stewart D, Stappert J, Nelson W, Marrs J . Genetic and biochemical dissection of protein linkages in the cadherin-catenin complex. Proc Natl Acad Sci U S A. 1995; 92(11):5067-71. PMC: 41849. DOI: 10.1073/pnas.92.11.5067. View

10.

KNUDSEN K, Soler A, Johnson K, Wheelock M . Interaction of alpha-actinin with the cadherin/catenin cell-cell adhesion complex via alpha-catenin. J Cell Biol. 1995; 130(1):67-77. PMC: 2120515. DOI: 10.1083/jcb.130.1.67. View

11.

Nagafuchi A, Takeichi M, Tsukita S . The 102 kd cadherin-associated protein: similarity to vinculin and posttranscriptional regulation of expression. Cell. 1991; 65(5):849-57. DOI: 10.1016/0092-8674(91)90392-c. View

12.

Vleminckx K, Vakaet Jr L, Mareel M, Fiers W, VAN Roy F . Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell. 1991; 66(1):107-19. DOI: 10.1016/0092-8674(91)90143-m. View

13.

Takeichi M . Morphogenetic roles of classic cadherins. Curr Opin Cell Biol. 1995; 7(5):619-27. DOI: 10.1016/0955-0674(95)80102-2. View

14.

Ozawa M, Kemler R . Molecular organization of the uvomorulin-catenin complex. J Cell Biol. 1992; 116(4):989-96. PMC: 2289345. DOI: 10.1083/jcb.116.4.989. View

15.

Shimoyama Y, Nagafuchi A, Fujita S, Gotoh M, Takeichi M, Tsukita S . Cadherin dysfunction in a human cancer cell line: possible involvement of loss of alpha-catenin expression in reduced cell-cell adhesiveness. Cancer Res. 1992; 52(20):5770-4. View

16.

Kinsella A, Green B, Lepts G, Hill C, Bowie G, Taylor B . The role of the cell-cell adhesion molecule E-cadherin in large bowel tumour cell invasion and metastasis. Br J Cancer. 1993; 67(5):904-9. PMC: 1968464. DOI: 10.1038/bjc.1993.169. View

17.

Gumbiner B . Signal transduction of beta-catenin. Curr Opin Cell Biol. 1995; 7(5):634-40. DOI: 10.1016/0955-0674(95)80104-9. View

18.

Takayama T, Shiozaki H, Shibamoto S, Oka H, Kimura Y, Tamura S . Beta-catenin expression in human cancers. Am J Pathol. 1996; 148(1):39-46. PMC: 1861624. View

19.

Shiozaki H, Oka H, Inoue M, Tamura S, Monden M . E-cadherin mediated adhesion system in cancer cells. Cancer. 1996; 77(8 Suppl):1605-13. DOI: 10.1002/(SICI)1097-0142(19960415)77:8<1605::AID-CNCR28>3.0.CO;2-2. View

20.

Inomata M, Ochiai A, Akimoto S, Kitano S, Hirohashi S . Alteration of beta-catenin expression in colonic epithelial cells of familial adenomatous polyposis patients. Cancer Res. 1996; 56(9):2213-7. View